Question 1

What are the most cited papers from Gem Pharmaceuticals (United States)?

Accepted Answer

The most cited paper from Gem Pharmaceuticals (United States) is "Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase" (Kambiz N. Alavian, Hongmei Li, Leon P. Collis et al., 2011), with 284 citations. Next come "Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma" (104) and "The Psychosocial Aspects of Complementary and Alternative Medicine" (82).

Question 2

Which research topics does Gem Pharmaceuticals (United States) publish most on?

Accepted Answer

By volume: Chemotherapy-induced cardiotoxicity and mitigation, Cancer Treatment and Pharmacology, Cancer, Hypoxia, and Metabolism and Chronic Lymphocytic Leukemia Research.

Question 3

Which fields of science does Gem Pharmaceuticals (United States) work in?

Accepted Answer

In all years, 63% of research at Gem Pharmaceuticals (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (59%), Biochemistry, Genetics and Molecular Biology (25%), Chemistry (4%). It does 1.5× the world's share of Health Sciences.

Question 4

Is Gem Pharmaceuticals (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.